Vertigo, a sensation of feeling off balance often characterized by a dizzy spell or feeling like the world around you is spinning, is a common complaint presented in medical settings. Despite its prevalence, it remains a challenging condition to diagnose and manage due to the myriad of potential causes and its subjective nature. This article aims to provide healthcare professionals with a comprehensive clinical approach to vertigo, from understanding its pathophysiology to diagnosing and managing the condition.
Vertigo is a subtype of dizziness, distinct from non-specific lightheadedness or imbalance. It is typically caused by a dysfunction in the vestibular system, which includes parts of the inner ear and brain that process sensory information involved with controlling balance and eye movements. Vertigo is further classified into peripheral and central based on the site of the lesion.
Peripheral vertigo is the most common type, accounting for 93% of cases. It arises due to disorders affecting the inner ear or vestibular nerve. Conditions like benign paroxysmal positional vertigo (BPPV), Meniere's disease, and vestibular neuritis fall under this category. Patients often present with acute, severe vertigo spells lasting minutes to hours, accompanied by nausea and vomiting. Auditory symptoms may also be present.
Central vertigo, on the other hand, is caused by disorders affecting the balance centers of the brain, such as the cerebellum and brainstem. Conditions like stroke, multiple sclerosis, and migraines can lead to central vertigo. Symptoms are often less intense but more persistent, with associated neurological signs like diplopia, dysarthria, or ataxia.
An accurate history and physical examination are crucial in diagnosing vertigo. The onset, duration, frequency, and associated symptoms can help differentiate between peripheral and central causes. For instance, episodic vertigo with a known trigger suggests BPPV, while vertigo with hearing loss and tinnitus may indicate Meniere's disease.
The physical examination should include a thorough neuro-otologic examination, including the Dix-Hallpike maneuver for BPPV and the head impulse test for vestibular neuritis. Neurological examination can help identify signs of central causes.
While the clinical evaluation can provide valuable clues, further investigations may be necessary for a definitive diagnosis. Audiometry can assess for hearing loss in Meniere's disease, while vestibular function tests like videonystagmography (VNG) or caloric testing can help confirm a peripheral cause. Neuroimaging, such as MRI, is indicated in suspected central vertigo or when vascular risk factors are present.
Management of vertigo is primarily directed at the underlying cause. In BPPV, canalith repositioning maneuvers like the Epley maneuver can be curative. Vestibular suppressants like meclizine can provide symptomatic relief, but their long-term use is discouraged due to potential impairment of vestibular compensation.
Meniere's disease can be managed with dietary modifications, diuretics, and intratympanic steroid injections. In refractory cases, surgical interventions may be considered. Central vertigo requires management of the underlying neurological condition.
Importantly, vestibular rehabilitation should be part of the management plan for all patients with vertigo. It includes exercises that promote central compensation for the loss of vestibular function, thus improving balance and reducing the risk of falls.
Vertigo is a complex clinical entity that requires a thorough understanding of its pathophysiology, careful clinical evaluation, and appropriate diagnostic workup. By adopting a systematic approach, healthcare professionals can accurately diagnose and manage this condition, thereby improving patient outcomes. As our understanding of vertigo continues to evolve, it is crucial for healthcare professionals to stay updated on the latest diagnostic and therapeutic strategies to provide the best possible care for their patients.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation